QUIPT HOME MEDICAL CORP (QIPT)

CA74880P1045 - Common Stock

2.62  +0.01 (+0.38%)

Fundamental Rating

3

QIPT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 109 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of QIPT have multiple concerns. QIPT does not seem to be growing, but still is valued expensively.



Quickly go to:

3

1. Profitability

1.1 Basic Checks

QIPT had negative earnings in the past year.
In the past year QIPT had a positive cash flow from operations.
QIPT had negative earnings in 4 of the past 5 years.
Of the past 5 years QIPT 4 years had a positive operating cash flow.

1.2 Ratios

With a Return On Assets value of -1.99%, QIPT perfoms like the industry average, outperforming 48.15% of the companies in the same industry.
QIPT has a Return On Equity of -4.53%. This is comparable to the rest of the industry: QIPT outperforms 51.85% of its industry peers.
QIPT's Return On Invested Capital of 1.95% is in line compared to the rest of the industry. QIPT outperforms 44.44% of its industry peers.
Industry RankSector Rank
ROA -1.99%
ROE -4.53%
ROIC 1.95%
ROA(3y)-1.07%
ROA(5y)-4.6%
ROE(3y)-2.35%
ROE(5y)-13.29%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

QIPT has a Operating Margin of 1.76%. This is comparable to the rest of the industry: QIPT outperforms 47.22% of its industry peers.
QIPT's Operating Margin has improved in the last couple of years.
QIPT's Gross Margin of 73.60% is amongst the best of the industry. QIPT outperforms 90.74% of its industry peers.
In the last couple of years the Gross Margin of QIPT has remained more or less at the same level.
Industry RankSector Rank
OM 1.76%
PM (TTM) N/A
GM 73.6%
OM growth 3Y33.62%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.59%
GM growth 5Y1.35%

More info and screens

3

2. Health

2.1 Basic Checks

QIPT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
There is no outstanding debt for QIPT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of 0.66, we must say that QIPT is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.66, QIPT is doing worse than 69.44% of the companies in the same industry.
The Debt to FCF ratio of QIPT is 2.96, which is a good value as it means it would take QIPT, 2.96 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.96, QIPT is in the better half of the industry, outperforming 79.63% of the companies in the same industry.
A Debt/Equity ratio of 0.66 indicates that QIPT is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.66, QIPT perfoms like the industry average, outperforming 50.93% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 2.96
Altman-Z 0.66
ROIC/WACC0.23
WACC8.54%

2.3 Liquidity

A Current Ratio of 1.11 indicates that QIPT should not have too much problems paying its short term obligations.
QIPT's Current ratio of 1.11 is on the low side compared to the rest of the industry. QIPT is outperformed by 71.30% of its industry peers.
A Quick Ratio of 0.77 indicates that QIPT may have some problems paying its short term obligations.
QIPT has a worse Quick ratio (0.77) than 79.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.77

More info and screens

3

3. Growth

3.1 Past

QIPT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -114.29%.
EPS 1Y (TTM)-114.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-1.91%

3.2 Future

Based on estimates for the next years, QIPT will show a very strong growth in Earnings Per Share. The EPS will grow by 88.55% on average per year.
QIPT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.85% yearly.
EPS Next Y93.2%
EPS Next 2Y57.35%
EPS Next 3Y117.26%
EPS Next 5Y88.55%
Revenue Next Year3.69%
Revenue Next 2Y4.18%
Revenue Next 3Y24.22%
Revenue Next 5Y21.85%

3.3 Evolution

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for QIPT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for QIPT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

QIPT's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. QIPT is cheaper than 98.15% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of QIPT indicates a rather cheap valuation: QIPT is cheaper than 99.07% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 3.41
EV/EBITDA 3.67

4.3 Compensation for Growth

A more expensive valuation may be justified as QIPT's earnings are expected to grow with 117.26% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y57.35%
EPS Next 3Y117.26%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for QIPT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

QUIPT HOME MEDICAL CORP

NASDAQ:QIPT (12/18/2024, 11:45:22 AM)

2.62

+0.01 (+0.38%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap112.90M
Analysts
Price Target
Short Float %
Short Ratio
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.99%
ROE -4.53%
ROCE
ROIC
ROICexc
ROICexgc
OM 1.76%
PM (TTM) N/A
GM 73.6%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.11
Quick Ratio 0.77
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-114.29%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y93.2%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y